Monazol (Sertaconazole Nitrate)

• Monazol, an imidazole antifungal, is used to treat fungal infections of the vaginal tract.
• Vaginal candidiasis: reduces Candida overgrowth, alleviates itching, burning, and abnormal discharge.
• Yeast infection (candidiasis): restores normal vaginal flora and improves patient comfort.
• Recurrent vaginal candidiasis: helps prevent recurrence when used as prescribed.

• Sertaconazole nitrate inhibits the fungal enzyme lanosterol 14‑α‑demethylase, blocking ergosterol synthesis. This disruption compromises the integrity of the fungal cell membrane, leading to increased permeability, leakage of intracellular contents, and ultimately fungal cell death. The selective action targets pathogenic yeasts while sparing human cells.

Common Side Effects

• Local irritation or burning at the application site.
• Mild itching or redness.
• Vaginal discharge with a slight odor.
• Headache.
• Nausea.
• Temporary increase in vaginal itching before improvement.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis) with swelling, hives, or difficulty breathing.
• Persistent or worsening vaginal irritation.
• Signs of secondary infection (fever, foul odor, unusual discharge).
• Skin rash extending beyond the application area.
• Unexplained dizziness or fainting.
• Rare systemic hypersensitivity reactions.

Before using Monazol, consider the following precautions:

• Allergy assessment: ensure no known hypersensitivity to sertaconazole or other imidazoles.
• Pregnancy: discuss potential risks with a healthcare professional before use.
• Breastfeeding: consult a physician to evaluate safety for nursing mothers.
• Concomitant vaginal products: avoid using other medicated creams or douches simultaneously.
• Underlying conditions: inform the prescriber of any chronic vaginal or systemic illnesses.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Monazol may interact with other substances as follows:

Major Interactions (Avoid)

• Systemic azole antifungals (e.g., fluconazole, itraconazole): concurrent use may increase systemic exposure and toxicity.
• Strong CYP450 inhibitors: may alter metabolism of co‑administered drugs.

Moderate Interactions (Monitor Closely)

• Topical corticosteroids: may reduce antifungal efficacy.
• Vaginal lubricants or spermicides: could affect drug absorption.
• Hormonal contraceptives: monitor for reduced effectiveness, though evidence is limited.